Leonteq Securities AG Invests $321,000 in DaVita Inc. $DVA

Leonteq Securities AG acquired a new position in shares of DaVita Inc. (NYSE:DVA) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,828 shares of the company’s stock, valued at approximately $321,000.

Other hedge funds have also modified their holdings of the company. Elevation Wealth Partners LLC increased its stake in shares of DaVita by 147.3% during the 4th quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock worth $31,000 after purchasing an additional 165 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of DaVita during the 2nd quarter worth approximately $43,000. iSAM Funds UK Ltd purchased a new stake in DaVita in the 3rd quarter worth approximately $46,000. Stance Capital LLC purchased a new stake in DaVita in the 3rd quarter worth approximately $47,000. Finally, Smartleaf Asset Management LLC grew its stake in DaVita by 34.9% in the 3rd quarter. Smartleaf Asset Management LLC now owns 452 shares of the company’s stock worth $59,000 after acquiring an additional 117 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Barclays lifted their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. TD Cowen lifted their target price on shares of DaVita from $144.00 to $201.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. UBS Group lifted their target price on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Finally, Truist Financial lifted their target price on shares of DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a research note on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $199.17.

Insider Buying and Selling at DaVita

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the transaction, the chief financial officer owned 132,434 shares in the company, valued at $25,440,571.40. This trade represents a 27.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by company insiders.

DaVita Stock Down 0.1%

Shares of DVA opened at $198.39 on Friday. The firm has a market cap of $12.74 billion, a PE ratio of 18.40, a price-to-earnings-growth ratio of 0.65 and a beta of 0.84. The company’s fifty day moving average is $162.93 and its two-hundred day moving average is $138.13. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $202.69.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. The company had revenue of $3.42 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. DaVita’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter last year, the business earned $2.00 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities research analysts anticipate that DaVita Inc. will post 15.07 earnings per share for the current year.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.